We previously reported that TNF downregulates PTPRS in RA FLS through a GSK3β-dependent pathway and that combination treatment of suboptimal doses of m1 with TNFi enhances the therapeutic response of each agent in the mouse CIA model (12). Here, PTPRS is linked to rheumatoid arthritis.